Analysis of FOXO1 mutations in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of newly diagnosed lymphomas and has an overall cure rate of approximately 60%. Previously, we observed FOXO1 mutations in non-Hodgkin lymphoma patient samples. To explore the effects of FOXO1 mutations, we assessed FOXO1 status in 279 DL...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Trinh, Diane L., Scott, David W., Morin, Ryan D., Mendez-Lago, Maria, An, Jianghong, Jones, Steven J. M., Mungall, Andrew J., Zhao, Yongjun, Schein, Jacqueline, Steidl, Christian, Connors, Joseph M., Gascoyne, Randy D., Marra, Marco A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2013
Soggetti:
Lymphoid Neoplasia
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3643765/
https://ncbi.nlm.nih.gov/pubmed/23460611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-01-479865
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi